The FDA has granted orphan drug designation to onvansertib as a potential treatment for CMML, a form of blood cancer.
Columnist and caregiver Samuel Ike shares his strategy of honestly and lovingly talking to his mother when there's bad news ...
An experimental treatment containing two naturally occurring pancreatic enzymes may be able to reduce the growth of cancer, a ...
A treatment regimen using Zenbexus can reduce the risk of disease progression in people with hard-to-treat multiple myeloma, ...
An EU committee is urging that an approved myeloma drug also be cleared for use as part of a combo treatment after a ...
When a sudden wave of exhaustion washes over columnist Gina Diamante, the thought of a multiple myeloma relapse comes rushing in, too.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results